Nonetheless, it was notable that CEA was much more efficient in AD than other pathological phenotypes [24, 25] in NSCLC, and the majority of previous studies mixed with other pathological phenotypes could attenuate the prognostic efficacy of CEA. This evidence concerns the gene CEACAM5 and Alzheimer disease.